ETPOS

European Transfusion Practice and Outcome Study

A multi-central evaluation of standard of transfusion care and clinical outcome for elective surgical patients: a Prospective Observational International Multi-Center Study
ETPOS is a prospective observational multi–center international study. The aim of the ETPOS study is to describe differences in transfusion habits throughout Europe and to correlate these habits to perioperative outcome parameters. Special focus is put on the number of packed red blood cells (PRBCs) transfused and the ratio of PRBCs to other blood products or coagulation factors in the operating room. Furthermore the motivation of physicians to transfuse PRBC and blood products in the operating room will be investigated.
Primary endpoint is the amount of PRBC and blood products and coagulation factors transfused.
Secondary endpoints are the trigger for and factors determining transfusion of PRBC and blood products in different regions of Europe, postoperative mortality within 30 days ,length of hospital stay, unplanned admission to the ICU, type and frequency of usage of blood conserving techniques.

  • Chief Investigator: PD Dr. Jens Meier MD (University Hospital Tübingen)
  • Sponsor: ESA Clinical Trial Network
  • National Coordinator: Prof. Dr. S. De Hert
  • Investigators UZ Gent: Prof. Dr. L. De Baerdemaeker , Dr. J. Van Limmen, Dr. P. Wyffels
  • Timeline: 3 consecutive months in recruitment period 01/04/2013-31/12/2013 (UZ Gent: 02/09/2013 - 02/12/2013)
  • Clinical Trials.gov identifier: NCT01604083